• BARD, J.A., ZGOMBICK, J., ADHAM, N., VAYSSE, P., BRANCHEK, T.A. & WEINSHANK, R.L. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem., 268, 2342223426.
  • BATES, D.M. & WATTS, D.G. (1988). In: Non-linear regression analysis and its applications, pp. 107108, New York: Wiley.
  • BERTIN, B., FREISSMUTH, M., BREYER, R.M., SCHUTZ, W., STROSBERG, A.D. & MARULLO, S. (1992). Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J. Biol. Chem., 267, 82008206.
  • BOYLAND, P.S., EASTWOOD, S., ELLIS, C., BERGSMA, D., JONES, B.J., GLOGER, I.S., UPTON, N. & MIDDLEMISS, D.N. (1996). High specific activity [3H]-5-CT binding: correlation of guinea-pig cortex with human cloned 5-HT7 receptors. Br. J. Pharmacol., 117, 132P.
  • CHENG, Y. & PRUSOFF, W.H. (1973). Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol., 22, 30993108.
  • CRAIG, D.A. (1993). The Cheng-Prussof Relationship: something lost in the translation. TiPS, 14, 8991.
  • DE VIVO, M. & MAAYANI, S. (1986). Characterisation of 5-hydroxytryptamine1A-receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea-pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther., 238, 248252.
  • DUMUIS, A., BOUHELAL, R., SEBBEN, M., CORY, R. & BOCKAERT, J. (1988). A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol. Pharmacol., 34, 880887.
  • FLETCHER, A., FORSTER, E.A., BILL, D.J., BROWN, G., CLIFFE, I.A., HARTLEY, J.E., JONES, D.E., MCLENACHAN, A., STANHOPE, K.J., CRITCHLEY, D.J.P., CHILDS, K.J., MIDDLEFELL, V.C., LANFUMEY, L., CORRADETTI, R., LAPORTE, A-M., GOZLAN, H., HAMON, M. & DOURISH, C.T. (1996). Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav. Brain Res., 73, 337353.
  • FORBES, I.T., DABBS, S., DUCKWORTH, D.M., JENNINGS, A.J., KING, F.D., LOVELL, P.J., COLLIN, L., BROWN, A.M., HAGAN, J.J., MIDDLEMISS, D.N., RILEY, G.J., THOMAS, D.R. & UPTON, N. (1998). (R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzene sulfonamide: The First Selective 5-HT7 Receptor Antagonist. J. Med. Chem., 41, 655657.
  • GROSSMAN, C.J., KILPATRICK, G.J. & BUNCE, K.T. (1993). Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br. J. Pharmacol., 109, 618624.
  • HOYER, D. & BODDEKE, H.W.G.M. (1993). Partial agonists, full agonists, antagonists: dilemmas of definition. TiPS., 14, 270275.
  • HOYER, D., GLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, F.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157243.
  • HUTSON, P.H., BRISTOW, L.J., THORN, L. & TRICKLEBANK, M.D. (1991). R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br. J. Pharmacol., 103, 20372044.
  • JASPER, J.R., TO, Z.P., KOSAKA, A., EGLEN, R.M. & CHANG, D.J. (1997). Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7(b)). Br. J. Pharmacol., 122, 126132.
  • LOVENBERG, T.W., BARON, B., DE LECEA, L., MILLER, J.D., PROSSER, R.A., REA, M.A., FOYE, P.E., RACKE, M., SLONE, A.L., SIEGEL, B.W., DANIELSON, P.E., SUTCLIFFE, J.G. & ERLANDER, M.G. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythyms. Neuron, 11, 449458.
  • MARKSTEIN, R., HOYER, D. & ENGEL, G. (1986). 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol., 333, 335341.
  • SALOMON, Y. (1979). Adenylate cyclase assay. Adv. in Cyclic Nuc. Res., 10, 3555.
  • SCHOEFFTER, P. & HOYER, D. (1988). Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol., 95, 975985.
  • SELBIE, L.A. & HILL, S.J. (1998). G-protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. TiPS, 19, 8793.
  • SHENKER, A., MAAYANI, S., WEINSTEIN, H. & GREEN, J.P. (1987). Pharmacological characterisation of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea-pig hippocampal membranes. Mol. Pharmacol., 31, 357367.
  • TANG, W.J. & GILMAN, A.G. (1991). Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science, 254, 15001503.
  • THOMAS, D.R., GITTINS, S.A., COLLIN, L.L., MIDDLEMISS, D.N., RILEY, G., HAGAN, J., GLOGER, I., ELLIS, C.E., FORBES, I.T. & BROWN, A.M. (1998). Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719. Br. J. Pharmacol., 124, 13001306.
  • THOMAS, D.R., MIDDLEMISS, D.N., TAYLOR, S.G., NELSON, P. & BROWN, A.M. (1999). 5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors. Br. J. Pharmacol., 126, 14P.
  • TO, Z.P., BONHAUS, D.W., EGLEN, R.M. & JAKEMAN, L.B. (1995). Characterisation and distribution of putative 5-ht7 receptors in guinea-pig brain. Br. J. Pharmacol., 115, 107116.
  • TSOU, A.P., KOSAKA, A., BACH, C., ZUPPAN, P., YEE, C., TOM, L., ALVAREZ, R., RAMSEY, S., BONHAUS, D.W., STEFANICH, E., JAKEMAN, L., EGLEN, R.M. & CHAN, H.W. (1994). Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J. Neurochem., 63, 456464.